Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2026-05-29 @ 12:34 PM
Study NCT ID:
NCT00378235
Status:
WITHDRAWN
Last Update Posted:
2014-11-13
First Post:
2006-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma
Sponsor:
INSYS Therapeutics Inc
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent Malignant Glioma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | neurosurgery, craniotomy | View |
| None | convection-enhanced delivery | View |
| None | CNS interstitial infusion | View |
| None | recombinant toxins | View |
| None | malignant glioma, recurrent | View |
| None | catheter, | View |
| None | intratumoral therapy | View |
| None | positive pressure microinfusion | View |